FDA Approves New Drug for Difficult-to-Treat Herpes
The FDA has approved Hovilpri (pritelivir) to treat herpes simplex virus (HSV) lesions that do not respond to standard antiviral therapies in adults with weakened immune systems. The oral drug is approved for adults with immunocompromising conditions whose …